# RxMP Therapeutics, Inc. — Form D

RxMP Therapeutics, Inc. of MIAMI, FL, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-21. The offering totals $3.0M, of which $1.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-04-21
- Form: D
- Accession: 0001857713-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.0M
- Remaining: $2.0M
- Minimum investment: $10K
- Investors: 39
- Date of first sale: 2021-03-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-396539

## Issuer

- Name: RxMP Therapeutics, Inc.
- CIK: 0001857713
- Entity type: Corporation
- Jurisdiction: FLORIDA
- Incorporated: 2017
- Address: 790 N.W. 107TH AVENUE, MIAMI, FL, 33172
- Phone: 215-872-9055

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Rifat Pamukcu | Director | Memphis, TN |
| Sue Van | Director | Miami, FL |
| Jy Wenche | Director | Miami, FL |
| Rifat Pamukcu | Executive Officer | Memphis, TN |
| Jy Wenche | Executive Officer | Miami, FL |
| Rifat Pamukcu | Promoter | Memphis, TN |
| Jy Wenche | Promoter | Miami, FL |

## More

- [CIK 1857713 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1857713&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001857713-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.